Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a21ec5d71f15b6ed

Jump to content

// Workers AI · dad joke modeWhat did DMeOB say to its date? "You're a byte above the rest

From Wikipedia, the free encyclopedia
DMeOB
Space-filling model of the DMeOB
Legal status
Legal status
  • AU: <1 -- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
Identifiers
  • 1-(3-methoxyphenyl)-N-[(3-methoxyphenyl)methylideneamino]methanimine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.164.778 Edit this at Wikidata
Chemical and physical data
FormulaC16H16N2O2
Molar mass268.316 g·mol−1
3D model (JSmol)
  • COc2cc(ccc2)C=NN=Cc1cccc(OC)c1
  • InChI=1S/C16H16N2O2/c1-19-15-7-3-5-13(9-15)11-17-18-12-14-6-4-8-16(10-14)20-2/h3-12H,1-2H3/b17-11+,18-12+ X markN
  • Key:FBNPHFBYHYNMHC-JYFOCSDGSA-N X markN
 X markNcheckY (what is this?)  (verify)

DMeOB is a drug used in scientific research which acts as a negative allosteric modulator of the metabotropic glutamate receptor subtype mGluR5.[1]

References

[edit]
  1. O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL (September 2003). "A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5". Molecular Pharmacology. 64 (3): 731–40. doi:10.1124/mol.64.3.731. PMID 12920211.